ANGIOSTOMY CANNULA MARKET ANALYSIS

Market News

Global Angiostosmy Cannula Market : Key Developments

 In August 2020, Nocca Robotics Pvt Ltd., an incubate company at IIT Kanpur, India, launched a High-Flow Oxygen Therapy Device, Noccarc H210. The HFOT (High-Flow Oxygen Therapy Device) provides humidified oxygen-rich air to the patients through a nasal cannula, thus increasing the oxygen level supplied to the blood. HFOT provides easy oral suctioning and expectoration. The heated and humidified gas also enhances epithelial muco-ciliary, thus lowering the risk of respiratory complications, such as pneumonia and delirium. The use of cannula in the HFOT makes it easy for the patient to communicate with the healthcare professionals and reduces the risk of tomophobia to the patient caused due to intubation.

In October 2022, the developers of a cannula for minimally-invasive central aortic perfusion-MIC-Cannula, received the European Association for Cardio-Thoracic Surgery (EACTS) Techno-College Innovation Award 2022. The device allows antegrade perfusion in a minimally invasive setting.

In June 2022, Prollenium Medical Technologies, a Canada-based company focused exclusively on the research and manufacturing of dermal fillers, announced that it had acquired SofFil- a developer of medical cannulas for expansion of its product portfolio.

In February 2022, Gilde Healthcare, a specialist healthcare investor, acquired EUROPIN, a an international developer and manufacturer of customized pen cannulas and lancet needles for diabetic use. The acquisition helps Gilde Healthcare to form an integrated contract manufacturer for tailor-made cannulas and cannula systems.